Table 3:

Effect of dietary portfolios high and low in monounsaturated fatty acids (MUFA) on blood lipids, C-reactive protein and blood pressure in 24 study participants (data presented as means)

Variable	High-MUFA portfolio, n = 12			Low-MUFA portfolio, n = 12			Treatment difference* (95% CI)	p value
	Baseline	Treatment		Baseline	Treatment
	Wk 4	Wk 6	Wk 8	Wk 4	Wk 6	Wk 8
Body weight, kg	82.10	81.85	81.33	78.70	79.00	77.47	0.31 (−0.51 to 0.78)	0.19
Cholesterol, mmol/L
Total	5.36	4.78	4.54	5.37	4.37	4.48	0.16 (−0.11 to 0.49)	0.24
LDL	3.61	2.97	2.81	3.49	2.67	2.73	0.08 (−0.13 to 0.33)	0.43
HDL	1.00	1.14	1.13	1.09	1.08	1.10	0.12 (0.05 to 0.21)	0.003
Triglycerides	1.64	1.49	1.33	1.72	1.37	1.41	0.00 (−0.26 to 0.22)	0.92
Apolipoprotein, g/L
AI	1.27	1.38	1.38	1.34	1.30	1.31	0.12 (0.05 to 0.18)	0.001
B	1.08	0.92	0.89	1.06	0.85	0.86	0.02 (−0.04 to 0.08)	0.50
Ratios
Total:HDL cholesterol	5.46	4.30	4.12	4.94	4.10	4.10	−0.28 (−0.59 to −0.04)	0.025
LDL:HDL cholesterol	3.68	2.68	2.56	3.23	2.50	2.51	−0.22 (−0.41 to −0.03)	0.032
Apolipoprotein B:AI	0.86	0.68	0.65	0.79	0.65	0.66	−0.04 (−0.07 to 0.00)	0.046
High-sensitivity C-reactive protein, mg/L	1.87	0.89	0.81	1.50	1.50	1.85	−1.27 (−1.76 to −0.39)	0.003
Blood pressure, mm Hg
Systolic	122	121	119	120	117	118	2 (−3 to 7)	0.40
Diastolic	75	73	72	71	69	71	1 (−2 to 4)	0.45

Note: CI = confidence interval, HDL = high-density lipoprotein, LDL = low-density lipoprotein.

^*Difference in change over time between high- and low-MUFA groups, by repeated-measures analysis.